• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Multi-component sleep-mood group interventions may improve insomnia symptoms in young adults

byJayden BerdugoandAlex Chan
November 14, 2024
in Chronic Disease, Neurology, Psychiatry
Reading Time: 2 mins read
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Share on FacebookShare on Twitter

1. In this pilot randomized controlled trial, the Sleep Mood Intervention: Life Effectively (SMILE) intervention was associated with improvements in insomnia in university students.

Evidence rating level: 1 (Excellent)

Insomnia has a major burden on public health and can have serious long-term physical and mental health effects if left untreated. A population at a high risk for sleep problems include university students which may be due to specific challenges that arise during this phase in life as balancing stress and developing greater independence. There is much research to support the use of cognitive behavioural therapy for insomnia (CBT-I), involving changing negative attitudes through the use of cognitive restructuring. In addition to CBT-I, mindfulness interventions, promoting being present in the moment, have promising results, specifically on reducing stress and anxiety. To study the effectiveness of mindfulness counselling on insomnia in university students, a randomized controlled trial created the Sleep Mood Intervention: Life Effectively (SMILE) intervention. The participants were assigned to the SMILE intervention group and a waiting list control group is a 2:1 ratio. The participants completed the Insomnia Severity Index (ISI) and those with a score of ≥ 10 were eligible for further screening including a face-to-face diagnostic interview using the M.I.N.I Plus International Neuropsychiatric Interview. Several inclusion criteria were listed including self-reported sleep complaints (ISI score ≥ 10), university enrollment, 18 years or older, English proficiency, and willing to participate in a 4-week program. After randomization, 23 people were assigned to the SMILE group and 12 were assigned to the waitlist group. Outcomes were assessed at baseline and after five weeks. Insomnia was assessed using the ISI, while depression was assessed using the Beck Depression Inventory II, and anxiety was assessed using the Hospital Anxiety and Depression Scale (HADS-A). The participants in the SMILE group had significantly lower severity levels of insomnia (M = 10.7, SD = 4.8) compared to the waitlist group (M = 14.7, SD = 4.9), post-test (t (33) = 2.33; p = .03, [95% CI: 0.51 to 7.52]. The impact of the SMILE intervention effects on insomnia severity was mediated by dysfunctional beliefs, with a reduction in dysfunctional beliefs associated with a decrease in insomnia severity, b = 1.12, [95% CI: -2.58 to -0.06]. There were no significant effects found for depression, d = 0.02 [95% CI: -0.35 tp 0.37], anxiety, d = 0.15 [95% CI: -0.16 to 0.53] and quality of life, d = 0.09 [95% CI: -0.25 to 0.42]. Overall, university students struggling with insomnia experienced improvements in their symptoms after participating in the four-week SMILE intervention.  

Click to read the study in BMC Psychology

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

2 Minute Medicine Rewind August 31, 2026

Positive psychotherapy may be similarly effective to traditional cognitive behavioural therapy for panic disorder

Tags: chronic diseasecounsellingInsomniapsychiatrypsychology
Previous Post

Direct oral anticoagulant scores predict bleeding risk in patients undergoing transcatheter valve replacement

Next Post

#VisualAbstract: No Difference Between Initial Intraosseous and Intravenous Vascular Access for Out-of-Hospital Cardiac Arrest

RelatedReports

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Weekly Rewinds

2 Minute Medicine Rewind August 31, 2026

August 31, 2026
Quick Take: Prevalence and Treatment of Depression, Anxiety, and Conduct Problems in US Children
Chronic Disease

Positive psychotherapy may be similarly effective to traditional cognitive behavioural therapy for panic disorder

August 21, 2026
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Chronic Disease

Medical or procedural abortion may not increase risk of psychotropic medication use after five years

July 27, 2026
Next Post
#VisualAbstract: No Difference Between Initial Intraosseous and Intravenous Vascular Access for Out-of-Hospital Cardiac Arrest

#VisualAbstract: No Difference Between Initial Intraosseous and Intravenous Vascular Access for Out-of-Hospital Cardiac Arrest

Plasma progranulin levels are correlated with left ventricular function recovery following myocardial infarction

American Academy of Pediatrics recommends standards for adverse event disclosures

Pressure-mediated biofeedback with pelvic floor muscle training for urinary incontinence

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Earlier Genetic Testing Predicts Bilateral Mastectomy in Young BRCA Carriers
  • Uterine-Sparing Mesh Repair Outperforms Hysterectomy for Prolapse
  • Daraxonrasib showed antitumor activity in previously treated RAS-mutant non–small-cell lung cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in